These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 22752894

  • 1. Gene delivery using helper virus-free HSV-1 amplicon vectors.
    Laimbacher AS, Fraefel C.
    Curr Protoc Neurosci; 2012 Jul; Chapter 4():Unit 4.14. PubMed ID: 22752894
    [Abstract] [Full Text] [Related]

  • 2. Gene delivery using helper virus-free HSV-1 amplicon vectors.
    Fraefel C.
    Curr Protoc Neurosci; 2007 Jul; Chapter 4():Unit 4.14. PubMed ID: 18428655
    [Abstract] [Full Text] [Related]

  • 3. Gene delivery using helper virus-free HSV-1 amplicon vectors.
    Fraefel C.
    Curr Protoc Hum Genet; 2002 Aug; Chapter 12():Unit 12.12. PubMed ID: 18428323
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome.
    Saeki Y, Fraefel C, Ichikawa T, Breakefield XO, Chiocca EA.
    Mol Ther; 2001 Apr; 3(4):591-601. PubMed ID: 11319922
    [Abstract] [Full Text] [Related]

  • 6. An enhanced packaging system for helper-dependent herpes simplex virus vectors.
    Stavropoulos TA, Strathdee CA.
    J Virol; 1998 Sep; 72(9):7137-43. PubMed ID: 9696807
    [Abstract] [Full Text] [Related]

  • 7. Expression of vhs and VP16 during HSV-1 helper virus-free amplicon packaging enhances titers.
    Bowers WJ, Howard DF, Brooks AI, Halterman MW, Federoff HJ.
    Gene Ther; 2001 Jan; 8(2):111-20. PubMed ID: 11313780
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Improved packaging system for generation of high-level noncytotoxic HSV-1 amplicon vectors using Cre-loxP site-specific recombination to delete the packaging signals of defective helper genomes.
    Zaupa C, Revol-Guyot V, Epstein AL.
    Hum Gene Ther; 2003 Jul 20; 14(11):1049-63. PubMed ID: 12885345
    [Abstract] [Full Text] [Related]

  • 10. A novel 'piggyback' packaging system for herpes simplex virus amplicon vectors.
    Pechan PA, Fotaki M, Thompson RL, Dunn R, Chase M, Chiocca EA, Breakefield XO.
    Hum Gene Ther; 1996 Oct 20; 7(16):2003-13. PubMed ID: 8930661
    [Abstract] [Full Text] [Related]

  • 11. Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas.
    Pechan PA, Herrlinger U, Aghi M, Jacobs A, Breakefield XO.
    J Gene Med; 1999 Oct 20; 1(3):176-85. PubMed ID: 10738566
    [Abstract] [Full Text] [Related]

  • 12. A novel approach for herpes simplex virus type 1 amplicon vector production, using the Cre-loxP recombination system to remove helper virus.
    Logvinoff C, Epstein AL.
    Hum Gene Ther; 2001 Jan 20; 12(2):161-7. PubMed ID: 11177553
    [Abstract] [Full Text] [Related]

  • 13. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap.
    Conway JE, Zolotukhin S, Muzyczka N, Hayward GS, Byrne BJ.
    J Virol; 1997 Nov 20; 71(11):8780-9. PubMed ID: 9343238
    [Abstract] [Full Text] [Related]

  • 14. Increased transcomplementation properties of plasmids carrying HSV-1 origin of replication and packaging signals.
    Berthomme H, Fournel S, Epstein AL.
    Virology; 1996 Feb 15; 216(2):437-43. PubMed ID: 8607275
    [Abstract] [Full Text] [Related]

  • 15. Construction and packaging of herpes simplex virus/adeno-associated virus (HSV/AAV) Hybrid amplicon vectors.
    Saydam O, Glauser DL, Fraefel C.
    Cold Spring Harb Protoc; 2012 Mar 01; 2012(3):352-6. PubMed ID: 22383640
    [Abstract] [Full Text] [Related]

  • 16. Herpes simplex virus type 1-derived recombinant and amplicon vectors.
    Fraefel C, Marconi P, Epstein AL.
    Methods Mol Biol; 2011 Mar 01; 737():303-43. PubMed ID: 21590403
    [Abstract] [Full Text] [Related]

  • 17. Examination of conditions affecting the efficiency of HVS-1 amplicon packaging.
    Wu X, Leduc Y, Cynader M, Tufaro F.
    J Virol Methods; 1995 Mar 01; 52(1-2):219-29. PubMed ID: 7769035
    [Abstract] [Full Text] [Related]

  • 18. Generation of high-titer defective HSV-1 vectors.
    Neve RL, Lim F.
    Curr Protoc Neurosci; 2013 Jan 01; Chapter 4():Unit 4.13. PubMed ID: 23315945
    [Abstract] [Full Text] [Related]

  • 19. HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells.
    Johnston KM, Jacoby D, Pechan PA, Fraefel C, Borghesani P, Schuback D, Dunn RJ, Smith FI, Breakefield XO.
    Hum Gene Ther; 1997 Feb 10; 8(3):359-70. PubMed ID: 9048203
    [Abstract] [Full Text] [Related]

  • 20. Murine Bone Marrow-Derived Dendritic Cells Transduced by Light-Helper-Dependent Herpes Simplex Virus-1 Amplicon Vector Acquire a Mature Dendritic Cell Phenotype.
    Oz-Arslan D, Tsitoura E, Kazazi D, Kouvatsis V, Epstein AL, Mavromara P.
    Hum Gene Ther Methods; 2015 Jun 10; 26(3):93-102. PubMed ID: 26046494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.